Literature DB >> 33057700

Intensive but tender care for infant ALL.

Hiroto Inaba1, Ching-Hon Pui1.   

Abstract

Year:  2020        PMID： 33057700      PMCID： PMC7568033          DOI： 10.1182/blood.2020007863

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  10 in total

1.  Improved outcome with hematopoietic stem cell transplantation in a poor prognostic subgroup of infants with mixed-lineage-leukemia (MLL)-rearranged acute lymphoblastic leukemia: results from the Interfant-99 Study.

Authors:  Georg Mann; Andishe Attarbaschi; Martin Schrappe; Paola De Lorenzo; Christina Peters; Ian Hann; Giulio De Rossi; Maria Felice; Birgitte Lausen; Thierry Leblanc; Tomasz Szczepanski; Alina Ferster; Gritta Janka-Schaub; Jeffrey Rubnitz; Lewis B Silverman; Jan Stary; Myriam Campbell; Chi Kong Li; Ram Suppiah; Andrea Biondi; Ajay Vora; Maria Grazia Valsecchi; Rob Pieters
Journal:  Blood       Date:  2010-06-30       Impact factor: 22.113

2.  Outcome of Infants Younger Than 1 Year With Acute Lymphoblastic Leukemia Treated With the Interfant-06 Protocol: Results From an International Phase III Randomized Study.

Authors:  Rob Pieters; Paola De Lorenzo; Philip Ancliffe; Luis Alberto Aversa; Benoit Brethon; Andrea Biondi; Myriam Campbell; Gabriele Escherich; Alina Ferster; Rebecca A Gardner; Rishi Sury Kotecha; Birgitte Lausen; Chi Kong Li; Franco Locatelli; Andishe Attarbaschi; Christina Peters; Jeffrey E Rubnitz; Lewis B Silverman; Jan Stary; Tomasz Szczepanski; Ajay Vora; Martin Schrappe; Maria Grazia Valsecchi
Journal:  J Clin Oncol       Date:  2019-07-08       Impact factor: 44.544

3.  Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia.

Authors:  M Dördelmann; A Reiter; A Borkhardt; W D Ludwig; N Götz; S Viehmann; H Gadner; H Riehm; M Schrappe
Journal:  Blood       Date:  1999-08-15       Impact factor: 22.113

4.  Significance of ethnicity in the risk of acute graft-versus-host disease and leukemia relapse after unrelated donor hematopoietic stem cell transplantation.

Authors:  Yasuo Morishima; Takakazu Kawase; Mari Malkki; Satoko Morishima; Stephen Spellman; Koichi Kashiwase; Shunichi Kato; Anne Cesbron; Jean-Marie Tiercy; David Senitzer; Andrea Velardi; Effie W Petersdorf
Journal:  Biol Blood Marrow Transplant       Date:  2013-06-06       Impact factor: 5.742

Review 5.  Immunotherapy in pediatric acute lymphoblastic leukemia.

Authors:  Hiroto Inaba; Ching-Hon Pui
Journal:  Cancer Metastasis Rev       Date:  2019-12       Impact factor: 9.264

6.  How I treat infant leukemia.

Authors:  Patrick Brown; Rob Pieters; Andrea Biondi
Journal:  Blood       Date:  2018-11-20       Impact factor: 22.113

7.  Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region.

Authors:  Ching-Hon Pui; Paul S Gaynon; James M Boyett; Judith M Chessells; André Baruchel; Willem Kamps; Lewis B Silverman; Andrea Biondi; Dörthe O Harms; Etienne Vilmer; Martin Schrappe; Bruce Camitta
Journal:  Lancet       Date:  2002-06-01       Impact factor: 79.321

8.  Analysis of prognostic factors of acute lymphoblastic leukemia in infants: report on CCG 1953 from the Children's Oncology Group.

Authors:  Joanne M Hilden; Patricia A Dinndorf; Sharon O Meerbaum; Harland Sather; Doojduen Villaluna; Nyla A Heerema; Ron McGlennen; Franklin O Smith; William G Woods; Wanda L Salzer; Helen S Johnstone; Zoann Dreyer; Gregory H Reaman
Journal:  Blood       Date:  2006-03-23       Impact factor: 22.113

9.  A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial.

Authors:  Rob Pieters; Martin Schrappe; Paola De Lorenzo; Ian Hann; Giulio De Rossi; Maria Felice; Liisa Hovi; Thierry LeBlanc; Tomasz Szczepanski; Alice Ferster; Gritta Janka; Jeffrey Rubnitz; Lewis Silverman; Jan Stary; Myriam Campbell; Chi-Kong Li; Georg Mann; Ram Suppiah; Andrea Biondi; Ajay Vora; Maria Grazia Valsecchi
Journal:  Lancet       Date:  2007-07-21       Impact factor: 79.321

10.  A risk-stratified therapy for infants with acute lymphoblastic leukemia: a report from the JPLSG MLL-10 trial.

Authors:  Daisuke Tomizawa; Takako Miyamura; Toshihiko Imamura; Tomoyuki Watanabe; Akiko Moriya Saito; Atsushi Ogawa; Yoshihiro Takahashi; Masahiro Hirayama; Tomohiko Taki; Takao Deguchi; Toshinori Hori; Masashi Sanada; Shigeru Ohmori; Masami Haba; Akihiro Iguchi; Yuki Arakawa; Yuhki Koga; Atsushi Manabe; Keizo Horibe; Eiichi Ishii; Katsuyoshi Koh
Journal:  Blood       Date:  2020-10-15       Impact factor: 22.113
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.